Macrophage xCT deficiency drives immune activation and boosts responses to immune checkpoint blockade in lung cancer.
Tang B, Wang Y, Xu W, Zhu J, Weng Q, Chen W, Fang S, Yang Y, Qiu R, Chen M, Mao W, Xu M, Zhao Z, Cai S, Zhang H, Ji J.
Tang B, et al. Among authors: qiu r.
Cancer Lett. 2023 Feb 1;554:216021. doi: 10.1016/j.canlet.2022.216021. Epub 2022 Nov 29.
Cancer Lett. 2023.
PMID: 36455758